Literature DB >> 25901378

Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.

Debra Lynch Kelly1, Debra E Lyon1, Suzanne A Ameringer2, Ronald K Elswick2.   

Abstract

PURPOSE/
OBJECTIVES: To describe associations among symptoms, cytokines, and quality of life (QOL) of patients with chronic graft-versus-host disease (cGVHD).
DESIGN: Prospective, cross-sectional, cohort.
SETTING: The bone marrow transplantation unit at a National Cancer Institute-designated cancer center in Virginia. SAMPLE: 24 adults diagnosed with cGVHD.
METHODS: Data were collected for demographic factors, symptoms, and QOL from medical record and validated questionnaires. Serum was analyzed for cytokine levels. MAIN RESEARCH VARIABLES: cGVHD, symptoms, cytokines, C-reactive protein, and QOL.
FINDINGS: Participants reported multiple, concurrent symptoms. Cytokine levels were higher in participants with symptoms versus those without symptoms. Cytokine interleukin-6 correlated with lack of energy and dry mouth. Negative correlations were noted between QOL and symptoms.
CONCLUSIONS: Findings demonstrated multiple concurrent symptoms present in this sample and significant relationships among symptoms, cytokines, and QOL. IMPLICATIONS FOR NURSING: cGVHD is a serious condition affecting QOL in many individuals after bone marrow transplantation for many different cancers. Results from this pilot study indicate that patients experience multiple symptoms, including sexual dysfunction, that adversely affect QOL. Better understanding of the interrelated symptoms of cGVHD and the biomarkers associated with these symptoms may lead to targeted symptom management interventions.

Entities:  

Keywords:  C-reactive protein; bone marrow transplantation; cancer; chronic graft-versus-host disease; cytokines; inflammation; quality of life; symptoms

Mesh:

Substances:

Year:  2015        PMID: 25901378     DOI: 10.1188/15.ONF.265-275

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  9 in total

Review 1.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 2.  Biological Basis for the Clustering of Symptoms.

Authors:  Debra Lynch Kelly; Kristin Dickinson; Chao-Pin Hsiao; Nada Lukkahatai; Velda Gonzalez-Marrero; Margaret McCabe; Leorey N Saligan
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

Review 3.  Oral Chronic Graft-Versus-Host Disease.

Authors:  David Dean; Herve Sroussi
Journal:  Front Oral Health       Date:  2022-05-20

4.  Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.

Authors:  Leung Li; Stephen L Chan; Frankie Mo; Edwin P Hui; Jane Koh; Allen K C Chan; Nelson L S Tang; Kit F Lee; Paul B S Lai; Simon C H Yu; Winnie Yeo
Journal:  Cancer Manag Res       Date:  2019-04-04       Impact factor: 3.989

5.  Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Hui Xiong; Samuel Weeks; Adriana May; Teresa Gentile; Jessica Henty-Ridilla; Adam T Waickman; Avery August; Alaji Bah; Mobin Karimi
Journal:  iScience       Date:  2021-03-11

6.  Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.

Authors:  Mahinbanu Mammadli; Weishan Huang; Rebecca Harris; Aisha Sultana; Ying Cheng; Wei Tong; Jeffery Pu; Teresa Gentile; Shanti Dsouza; Qi Yang; Alaji Bah; Avery August; Mobin Karimi
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

7.  Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.

Authors:  Sencer Goklemez; Leorey N Saligan; Filip Pirsl; Noa G Holtzman; Alen Ostojic; Seth M Steinberg; Frances T Hakim; Jeremy J Rose; Zhigang Kang; Yunkai Yu; Liang Cao; Sandra A Mitchell; Annie Im; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2021-08-25       Impact factor: 5.483

8.  Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors.

Authors:  Aleksandra Kroemeke; Małgorzata Sobczyk-Kruszelnicka; Zuzanna Kwissa-Gajewska
Journal:  Qual Life Res       Date:  2017-09-12       Impact factor: 4.147

9.  Oral health-related quality of life of patients with oral chronic graft-versus-host disease.

Authors:  Juliette Stolze; Marlou Boor; Mette D Hazenberg; Henk S Brand; Judith E Raber-Durlacher; Alexa M G A Laheij
Journal:  Support Care Cancer       Date:  2021-04-21       Impact factor: 3.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.